lapachol has been researched along with Carcinoma, Anaplastic in 1 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Grandis, RA | 1 |
| Costa, AR | 1 |
| Moraes, CAF | 1 |
| Sampaio, NZ | 1 |
| Cerqueira, IH | 1 |
| Marques, WG | 1 |
| Guedes, APM | 1 |
| de Araujo-Neto, JH | 1 |
| Pavan, FR | 1 |
| Demidoff, FC | 1 |
| Netto, CD | 1 |
| Batista, AA | 1 |
| Resende, FA | 1 |
1 other study available for lapachol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Compl | 2022 |